image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Our latest issue will be released in 13 days, don't miss out!

Luceco - Net debt / EBITDA just 0.8x vs forecasts of 1.3x

March 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • LUCE
  • Price:
  • 140p
My comments last  December that Luceco was probably at the bottom of the downgrade cycle were nicely timed with the shares rallying over 50% after it said full year EBIT would now be towards the upper end of the guidance range (£20m-£22m). While Q4 was affected by customer de-stocking, this was offset by cost deflation benefits and pricing initiatives, which meant gross margin recovery in H2 was stronger than expected at 37.5%, vs 34% in H1. This more than compensated for Q4 revenues of -22% year-on-year versus -11% in Q3, with full year revenue falling around 10% to £206m. More impressive still, record free cash flow generation, of £30m on Liberum’s estimates,  resulted in much lower year end net debt than expected at £24m ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author